| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
BioInvent International AB (publ) (OTCGREY: BOVNF)
BOVNF Technical Analysis
5
| As on 10th Jun 2025 BOVNF STOCK Price closed @ 3.29 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.44 & Strong Sell for SHORT-TERM with Stoploss of 3.61 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BOVNFSTOCK Price
| Open | 3.29 | Change | Price | % |
| High | 3.29 | 1 Day | -1.41 | -30.00 |
| Low | 3.29 | 1 Week | -1.41 | -30.00 |
| Close | 3.29 | 1 Month | -1.41 | -30.00 |
| Volume | 463353 | 1 Year | 0.31 | 10.40 |
| 52 Week High 4.70 | 52 Week Low 2.98 | ||||
OTCGREY USA Most Active Stocks
| XANAF | 0.04 | -33.33% |
| RTTGF | 0.02 | 0.00% |
| IARED | 24.62 | % |
| CVMCA | 22.54 | -0.75% |
| JRVMF | 0.01 | 0.00% |
| GCEA | 29.00 | -21.20% |
| AHLD | 82.75 | -2.93% |
| BOVNF | 3.29 | -30.00% |
| BRTR | 50.27 | -0.51% |
| MAXC | 1.78 | 0.00% |
OTCGREY USA Top Gainers Stocks
OTCGREY USA Top Losers Stocks
| BOVNF Daily Charts |
BOVNF Intraday Charts |
Whats New @ Bazaartrend |
BOVNF Free Analysis |
|
|
BOVNF Important Levels Intraday
| RESISTANCE | 3.29 |
| RESISTANCE | 3.29 |
| RESISTANCE | 3.29 |
| RESISTANCE | 3.29 |
| RESISTANCE | 3.29 |
| RESISTANCE | 3.29 |
| RESISTANCE | 3.29 |
| RESISTANCE | 3.29 |
BOVNF Forecast July 2025
| 4th UP Forecast | 3.29 |
| 3rd UP Forecast | 3.29 |
| 2nd UP Forecast | 3.29 |
| 1st UP Forecast | 3.29 |
| 1st DOWN Forecast | 3.29 |
| 2nd DOWN Forecast | 3.29 |
| 3rd DOWN Forecast | 3.29 |
| 4th DOWN Forecast | 3.29 |
BOVNF Weekly Forecast
| 4th UP Forecast | 3.29 |
| 3rd UP Forecast | 3.29 |
| 2nd UP Forecast | 3.29 |
| 1st UP Forecast | 3.29 |
| 1st DOWN Forecast | 3.29 |
| 2nd DOWN Forecast | 3.29 |
| 3rd DOWN Forecast | 3.29 |
| 4th DOWN Forecast | 3.29 |
BOVNF Forecast2025
| 4th UP Forecast | 6.6 |
| 3rd UP Forecast | 5.54 |
| 2nd UP Forecast | 4.88 |
| 1st UP Forecast | 4.23 |
| 1st DOWN Forecast | 2.35 |
| 2nd DOWN Forecast | 1.7 |
| 3rd DOWN Forecast | 1.04 |
| 4th DOWN Forecast | -0.02 |
BioInvent International AB (publ) ( OTCGREY USA Symbol : BOVNF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BOVNF Business Profile
BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, rest of Europe, the United States, Japan, and internationally. Its lead drug candidate is BI-1206, a monoclonal antibody targeting CD32b, which is in Phase I/IIa clinical trials in patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia. The company is also developing cancer-associated regulatory T cells which modulate the immune system; and BI-1808 and BI-1910, an anti-TNFR2 antibody for the treatment of solid tumors and cutaneous T-cell lymphoma (CTCL). It has a strategic collaboration with Pfizer Inc. for the development of antibodies against tumour-associated myeloid cells; partnership and collaboration with Transgene to co-develop multi-functional oncolytic viruses for treatment of solid tumors; and a collaboration agreement with SkylineDx to characterize the gene expression and immunological signatures in tumors of patients pre-and post-treatment with BI-1206. The Company was incorporated in 1996 and is headquartered in Lund, Sweden. Address: The Gamma Building, Lund, Sweden, 223 70
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service